P. W. Muggleton

796 total citations
32 papers, 562 citations indexed

About

P. W. Muggleton is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, P. W. Muggleton has authored 32 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Pharmacology and 8 papers in Immunology. Recurrent topics in P. W. Muggleton's work include Immunodeficiency and Autoimmune Disorders (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Tuberculosis Research and Epidemiology (4 papers). P. W. Muggleton is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Tuberculosis Research and Epidemiology (4 papers). P. W. Muggleton collaborates with scholars based in United Kingdom, Germany and France. P. W. Muggleton's co-authors include Cynthia H. O'Callaghan, D. M. Ryan, J. Ungar, P F D’Arcy, Evelyn Howard, R. D. Foord, R. B. Sykes, J. R. Needham, Katherine E. Lawrence and Michael Webb and has published in prestigious journals such as The Lancet, Annals of the New York Academy of Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

P. W. Muggleton

32 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. W. Muggleton United Kingdom 13 186 144 115 81 77 32 562
J. W. Lightbown United Kingdom 11 153 0.8× 258 1.8× 87 0.8× 48 0.6× 86 1.1× 50 586
K Roholt Denmark 11 273 1.5× 167 1.2× 88 0.8× 115 1.4× 130 1.7× 22 716
P. Acred United Kingdom 14 311 1.7× 136 0.9× 236 2.1× 160 2.0× 145 1.9× 30 675
T Matsubara Japan 11 197 1.1× 156 1.1× 115 1.0× 30 0.4× 78 1.0× 32 450
S. Sugawara Japan 15 238 1.3× 237 1.6× 192 1.7× 65 0.8× 43 0.6× 64 733
Makoto Kida Japan 13 164 0.9× 240 1.7× 109 0.9× 40 0.5× 36 0.5× 36 459
Katsuhisa Nakata Japan 15 184 1.0× 204 1.4× 147 1.3× 147 1.8× 96 1.2× 28 710
V. ARIOLI Italy 15 316 1.7× 295 2.0× 99 0.9× 167 2.1× 263 3.4× 31 808
Janet M. Dewdney United Kingdom 15 368 2.0× 125 0.9× 42 0.4× 34 0.4× 28 0.4× 36 827
Poul Nielsen United Kingdom 18 425 2.3× 130 0.9× 93 0.8× 30 0.4× 32 0.4× 45 920

Countries citing papers authored by P. W. Muggleton

Since Specialization
Citations

This map shows the geographic impact of P. W. Muggleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. W. Muggleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. W. Muggleton more than expected).

Fields of papers citing papers by P. W. Muggleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. W. Muggleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. W. Muggleton. The network helps show where P. W. Muggleton may publish in the future.

Co-authorship network of co-authors of P. W. Muggleton

This figure shows the co-authorship network connecting the top 25 collaborators of P. W. Muggleton. A scholar is included among the top collaborators of P. W. Muggleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. W. Muggleton. P. W. Muggleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lawrence, Katherine E., P. W. Muggleton, & J. R. Needham. (1984). Preliminary study on the use of ceftazidime, a broad spectrum cephalosporin antibiotic, in snakes. Research in Veterinary Science. 36(1). 16–20. 31 indexed citations
2.
Muggleton, P. W.. (1981). Why ceftazidime?. Journal of Antimicrobial Chemotherapy. 8(suppl B). 1–3. 3 indexed citations
3.
O'Callaghan, Cynthia H., R. B. Sykes, D. M. Ryan, R. D. Foord, & P. W. Muggleton. (1976). Cefuroxime - A new cephalosporin antibiotic.. The Journal of Antibiotics. 29(1). 29–37. 80 indexed citations
4.
Holme, Tord, et al.. (1972). A trial to compare reactions and responses to BCG vaccine prepared from Copenhagen 1331 and glaxo 1077 strains. Tubercle. 53(2). 100–105. 5 indexed citations
5.
Holme, Tord, et al.. (1972). A trial to compare United Kingdom strength BCG vaccine with vaccine of double the moist weight content. Tubercle. 53(2). 106–110. 6 indexed citations
6.
Burland, W. L., et al.. (1968). Reactions to combined diphtheria, tetanus and pertussis vaccine: a comparison between plain vaccine and vaccine adsorbed on aluminium hydroxide.. Medical officer. 119(2). 17–19. 5 indexed citations
7.
Muggleton, P. W.. (1967). Vaccines against pertussis. Public Health. 81(5). 252–264. 12 indexed citations
8.
Muggleton, P. W.. (1966). The Use of Radioactive Isotopes in Tuberculosis Research.. Journal of the Royal Society of Medicine. 59(6). 584–584. 2 indexed citations
9.
Muggleton, P. W., et al.. (1964). EFFECT OF PROTAMINE SULPHATE ON EXPERIMENTAL TUMOURS IN MICE. The Lancet. 283(7330). 409–410. 12 indexed citations
10.
Muggleton, P. W., et al.. (1964). Laboratory Evaluation of a New Antibiotic—Cephaloridine (Ceporin). BMJ. 2(5419). 1234–1237. 52 indexed citations
11.
Smith, E. Lester, Leonard Mervyn, P. W. Muggleton, A. W. Johnson, & Neil Shaw. (1964). CHEMICAL ROUTES TO COENZYME B12 AND ANALOGUES*. Annals of the New York Academy of Sciences. 112(2). 565–574. 27 indexed citations
12.
Muggleton, P. W., et al.. (1963). THE FORMATION OF METABOLITES FROM CEPHALOSPORIN COMPOUNDS. Biochemical Journal. 89(2). 304–308. 24 indexed citations
13.
Ungar, J., et al.. (1962). Preparation and Properties of a Freeze-dried B.C.G. Vaccine of Increased Stability. BMJ. 2(5312). 1086–1089. 29 indexed citations
14.
D’Arcy, P F, et al.. (1960). The Anti-Inflammatory Action of Griseofulvin in Experimental Animals. Journal of Pharmacy and Pharmacology. 12(1). 659–665. 102 indexed citations
15.
Ungar, J., Paul Farmer, & P. W. Muggleton. (1956). Freeze-dried B.C.G. Vaccine. BMJ. 2(4992). 568–571. 23 indexed citations
16.
Ungar, J., et al.. (1954). The type specificity ofHaemophilus pertussis. Epidemiology and Infection. 52(4). 475–485. 3 indexed citations
17.
Muggleton, P. W., et al.. (1954). The Stability of Penicillin in Sugar-Coated Tablets. Journal of Pharmacy and Pharmacology. 6(1). 1048–1053. 1 indexed citations
18.
Ungar, J., et al.. (1954). EFFECT OF PYRIDOXINE ON THE ACTION OF ISONIAZID. The Lancet. 264(6831). 220–221. 16 indexed citations
19.
Muggleton, P. W. & Michael Webb. (1952). The exocellular bacteriolytic system of soil actinomyces II. A further investigation of the lytic system. Biochimica et Biophysica Acta. 8(4). 431–441. 8 indexed citations
20.
Muggleton, P. W. & Michael Webb. (1952). The exocellular bacteriolytic system of soil actinomyces III. The separation and characterisation of the proteolytic enzymes. Biochimica et Biophysica Acta. 8(5). 526–536. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026